
    
      Eligible participants will receive one injection of either Sanofi Pasteur Meningococcal
      (Groups A and C) Polysaccharide Vaccine or Lanzhou Institute for Biological Products
      Meningococcal (Groups A and C) Polysaccharide Vaccine and will be monitored for safety and
      immunogenicity for up to 30 days post-vaccination.
    
  